514336 GENESIS

Genesis IBRC India Share Price

 

 

Start SIP in GENESIS

Start SIP
Genesis IBRC India live price: ₹101. It opened at ₹101 vs previous close ₹101; intraday high/low: ₹101/₹101. The 50 & 200 DMA stand at ₹89.07/₹74.30.

Genesis IBRC India Performance

  • Today's Low
  • ₹101
  • Today's High
  • ₹101
  • 52 Week Low
  • ₹18
  • 52 Week High
  • ₹185
  • Open Price₹101
  • Previous Close₹101
  • Volume102
  • 50 DMA₹89.07
  • 100 DMA₹87.83
  • 200 DMA₹74.30

Investment Returns

  • Over 1 Month + 31.17%
  • Over 3 Month + 11.11%
  • Over 6 Month + 55.41%
  • Over 1 Year + 450.71%

Smart Investing Starts Here Start SIP with Genesis IBRC India for Steady Growth!

Invest Now

Genesis IBRC India Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • -554.7
  • PEG Ratio
  • 12.1
  • Market Cap Cr
  • 131
  • P/B Ratio
  • 15.8
  • Average True Range
  • 4.66
  • EPS
  • -
  • Dividend Yield
  • 0
  • MACD Signal
  • 4.48
  • RSI
  • 65.77
  • MFI
  • 96.93

Genesis IBRC India Financials

Genesis IBRC India Technicals

EMA & SMA

Current Price
₹101.00
0 (0%)
pointer
  • Bearish Moving Average 2
  • Bullish Moving Average 14
  • 20 Day
  • ₹92.16
  • 50 Day
  • ₹89.07
  • 100 Day
  • ₹87.83
  • 200 Day
  • ₹74.30

Resistance and Support

101 Pivot Speed
  • R3 101.00
  • R2 101.00
  • R1 101.00
  • S1 101.00
  • S2 101.00
  • S3 101.00

Ratings

Master Rating

EPS Strenth

N/A

Price Strength

Buyer Demand

Group Rank

Genesis Ibrc India has an operating revenue of Rs. 4.38 Cr. on a trailing 12-month basis. Pre-tax margin of 0% needs improvement, ROE of 41% is exceptional. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is comfortably placed above its key moving averages, around 20% and 42% from 50DMA and 200DMA. From an O'Neil Methodology perspective, the stock has an EPS Rank of 0 which is a POOR score indicating inconsistency in earnings, a RS Rating of 98 which is GREAT indicating the outperformance as compared to other stocks, Buyer Demand at B+ which is evident from recent demand for the stock, Group Rank of 39 indicates it belongs to a strong industry group of Medical-Biomed/Biotech and a Master Score of D is close to being the worst. Overall, the stock has some relative strength and buyer demand but we want to see further fundamental performance to qualify as a growth stock.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Genesis IBRC India Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-02-14 Quarterly Results
2026-01-28 Preferential issue of shares
2025-11-14 Quarterly Results
2025-08-14 Quarterly Results
2025-05-29 Audited Results

Genesis IBRC India F&O

Genesis IBRC India Shareholding Pattern

11.33%
25.09%
63.58%

Genesis IBRC India FAQs

Genesis IBRC India share price is ₹101 As on 28 March, 2026 | 00:55

The Market Cap of Genesis IBRC India is ₹131.3 Cr As on 28 March, 2026 | 00:55

The P/E ratio of Genesis IBRC India is -554.7 As on 28 March, 2026 | 00:55

The PB ratio of Genesis IBRC India is 15.8 As on 28 March, 2026 | 00:55

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23